RadNet, Inc. (RDNT) Cash Flow Statement

The persistent gap between net income and operating cash flow, particularly in quarters with net losses, indicates that D&A and SBC are significant non-cash add-backs. In 2026Q1, a net loss of $33.5M was accompanied by $92.3M in operating cash flow, implying that reported losses may not reflect underlying cash generation. However, the reliance on SBC, which totaled $41.9M in 2026Q2, suggests that a portion of cash flow is not available to shareholders.

The FCF trajectory is highly volatile, with negative FCF in three of the last five quarters, driven by large capex outlays and working capital changes. The 2026Q2 FCF of $150.7M appears to benefit from a positive working capital adjustment of $24.8M, which may not be sustainable. Investors should monitor whether the company can maintain positive FCF margins above 20% given its capital-intensive imaging center model.

Capex has been consistently high, ranging from 8.9% to 57.5% of revenue, suggesting a mix of maintenance and growth spending. The spike in 2025Q4 likely reflects a major acquisition or expansion, as evidenced by the negative capex in that quarter (likely a data artifact) and the large acquisition outflows. This capital intensity implies that RadNet must generate strong operating cash flow to fund its expansion without increasing leverage.

The volatility in working capital changes suggests that RadNet's cash conversion cycle is not stable, possibly due to insurance reimbursements and provider payments. Positive working capital changes in some quarters (e.g., 2026Q1) may indicate improved collections, while negative changes in others (e.g., 2026Q2) could reflect inventory build-up or delayed payments. This makes quarterly FCF comparisons less meaningful without adjusting for these swings.

The company has not returned capital to shareholders via dividends or buybacks, instead deploying cash into acquisitions, which totaled $303.9M in 2026Q1 alone. This suggests management is prioritizing expansion over shareholder returns, which may be appropriate given the fragmented diagnostic imaging market. However, the high acquisition spend, combined with significant capex, raises questions about the sustainability of cash generation and the potential need for external financing.